Martin Sowden, Pharma Supply Chain Expert, PA ConsultingFrom Martin Sowden, Pharma Supply Chain Expert, PA ConsultingAll TechnologyFive Key Manufacturing Challenges in Autologous Commercial Cell and Gene TherapiesThe personalized nature of autologous CGT results in complex manufacturing challenges, driving costs high when transitioning from clinical to commercial scale.February 5, 2024Page 1 of 1
